247 related articles for article (PubMed ID: 18701505)
1. Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate.
Fu VX; Dobosy JR; Desotelle JA; Almassi N; Ewald JA; Srinivasan R; Berres M; Svaren J; Weindruch R; Jarrard DF
Cancer Res; 2008 Aug; 68(16):6797-802. PubMed ID: 18701505
[TBL] [Abstract][Full Text] [Related]
2. A loss of insulin-like growth factor-2 imprinting is modulated by CCCTC-binding factor down-regulation at senescence in human epithelial cells.
Fu VX; Schwarze SR; Kenowski ML; Leblanc S; Svaren J; Jarrard DF
J Biol Chem; 2004 Dec; 279(50):52218-26. PubMed ID: 15471867
[TBL] [Abstract][Full Text] [Related]
3. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site.
Ulaner GA; Vu TH; Li T; Hu JF; Yao XM; Yang Y; Gorlick R; Meyers P; Healey J; Ladanyi M; Hoffman AR
Hum Mol Genet; 2003 Mar; 12(5):535-49. PubMed ID: 12588801
[TBL] [Abstract][Full Text] [Related]
4. Loss of
Damaschke NA; Yang B; Bhusari S; Avilla M; Zhong W; Blute ML; Huang W; Jarrard DF
Cancer Res; 2017 Oct; 77(19):5236-5247. PubMed ID: 28775169
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer.
Bhusari S; Yang B; Kueck J; Huang W; Jarrard DF
Prostate; 2011 Nov; 71(15):1621-30. PubMed ID: 21432864
[TBL] [Abstract][Full Text] [Related]
6. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A
Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642
[TBL] [Abstract][Full Text] [Related]
7. Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
Paradowska A; Fenic I; Konrad L; Sturm K; Wagenlehner F; Weidner W; Steger K
Int J Oncol; 2009 Jul; 35(1):87-96. PubMed ID: 19513555
[TBL] [Abstract][Full Text] [Related]
8. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP
Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321
[TBL] [Abstract][Full Text] [Related]
9. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer.
Nakagawa H; Chadwick RB; Peltomaki P; Plass C; Nakamura Y; de La Chapelle A
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):591-6. PubMed ID: 11120891
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites.
Yang Y; Hu JF; Ulaner GA; Li T; Yao X; Vu TH; Hoffman AR
J Cell Biochem; 2003 Dec; 90(5):1038-55. PubMed ID: 14624463
[TBL] [Abstract][Full Text] [Related]
11. A methyl-deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate.
Dobosy JR; Fu VX; Desotelle JA; Srinivasan R; Kenowski ML; Almassi N; Weindruch R; Svaren J; Jarrard DF
Prostate; 2008 Aug; 68(11):1187-95. PubMed ID: 18459101
[TBL] [Abstract][Full Text] [Related]
12. Mutation of a single CTCF target site within the H19 imprinting control region leads to loss of Igf2 imprinting and complex patterns of de novo methylation upon maternal inheritance.
Pant V; Kurukuti S; Pugacheva E; Shamsuddin S; Mariano P; Renkawitz R; Klenova E; Lobanenkov V; Ohlsson R
Mol Cell Biol; 2004 Apr; 24(8):3497-504. PubMed ID: 15060168
[TBL] [Abstract][Full Text] [Related]
13. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch.
Li T; Vu TH; Ulaner GA; Littman E; Ling JQ; Chen HL; Hu JF; Behr B; Giudice L; Hoffman AR
Mol Hum Reprod; 2005 Sep; 11(9):631-40. PubMed ID: 16219628
[TBL] [Abstract][Full Text] [Related]
14. CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues.
Ulaner GA; Yang Y; Hu JF; Li T; Vu TH; Hoffman AR
Endocrinology; 2003 Oct; 144(10):4420-6. PubMed ID: 12960026
[TBL] [Abstract][Full Text] [Related]
15. A novel pathway links oxidative stress to loss of insulin growth factor-2 (IGF2) imprinting through NF-κB activation.
Yang B; Wagner J; Damaschke N; Yao T; Wuerzberger-Davis SM; Lee MH; Svaren J; Miyamoto S; Jarrard DF
PLoS One; 2014; 9(2):e88052. PubMed ID: 24558376
[TBL] [Abstract][Full Text] [Related]
16. CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2.
Kurukuti S; Tiwari VK; Tavoosidana G; Pugacheva E; Murrell A; Zhao Z; Lobanenkov V; Reik W; Ohlsson R
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10684-9. PubMed ID: 16815976
[TBL] [Abstract][Full Text] [Related]
17. Nonallelic transcriptional roles of CTCF and cohesins at imprinted loci.
Lin S; Ferguson-Smith AC; Schultz RM; Bartolomei MS
Mol Cell Biol; 2011 Aug; 31(15):3094-104. PubMed ID: 21628529
[TBL] [Abstract][Full Text] [Related]
18. Loss of imprinting of IGF2 and H19, loss of heterozygosity of IGF2R and CTCF, and Helicobacter pylori infection in laryngeal squamous cell carcinoma.
Grbesa I; Marinkovic M; Ivkic M; Kruslin B; Novak-Kujundzic R; Pegan B; Bogdanovic O; Bedekovic V; Gall-Troselj K
J Mol Med (Berl); 2008 Sep; 86(9):1057-66. PubMed ID: 18604514
[TBL] [Abstract][Full Text] [Related]
19. CTCF-dependent chromatin bias constitutes transient epigenetic memory of the mother at the H19-Igf2 imprinting control region in prospermatogonia.
Lee DH; Singh P; Tsai SY; Oates N; Spalla A; Spalla C; Brown L; Rivas G; Larson G; Rauch TA; Pfeifer GP; Szabó PE
PLoS Genet; 2010 Nov; 6(11):e1001224. PubMed ID: 21124827
[TBL] [Abstract][Full Text] [Related]
20. Alterations in expression of imprinted genes from the H19/IGF2 loci in a multigenerational model of intrauterine growth restriction (IUGR).
Gonzalez-Rodriguez P; Cantu J; O'Neil D; Seferovic MD; Goodspeed DM; Suter MA; Aagaard KM
Am J Obstet Gynecol; 2016 May; 214(5):625.e1-625.e11. PubMed ID: 26880735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
